is a Guillain-Barré variant causing rapid motor nerve damage, weakness, paralysis.

is a fast-growing leukemia with partially maturing myeloid cells.

is an aggressive bone marrow cancer linked to myelodysplastic (MDS) changes.

is a fast-growing blood cancer starting in the bone marrow.

is therapy-related blood cancers after alkylating chemotherapy, causing low blood counts.

are radiation-related blood cancers affecting bone marrow and reducing healthy blood cells.

are therapy-related blood cancers affecting bone marrow after topoisomerase II inhibitors.

is an aggressive blood cancer involving 11q23 (KMT2A) gene changes.

is a blood cancer with chromosome 16 change and abnormal eosinophils.

is a rare, aggressive blood cancer driven by BCR-ABL1 gene fusion.

is a fast-growing blood and bone marrow cancer with two CEBPA mutations.

is a fast-growing blood cancer of bone marrow with CEBPA mutations.

is a fast-growing blood cancer with a favorable genetic change.

is a rare, aggressive leukemia with chromosome 3 changes disrupting bone marrow.

is a rare, high-risk AML subtype with chromosome 3 rearrangements.

is an acute blood and bone marrow cancer with partial myeloid maturation.

is a fast-growing blood cancer (leukemia) of immature myeloid cells.

is an aggressive blood cancer caused by KMT2A (MLL) gene rearrangements.

is a blood cancer with CEBPA mutations causing immature white cells.

is an acute blood cancer of the bone marrow with NPM1 mutation.

is a leukemia with RUNX1 mutation and excess immature white cells (blasts).

is an aggressive blood cancer affecting bone marrow after myelodysplastic changes.

is a fast-growing blood cancer caused by acquired NPM1 gene changes.

is a fast-growing blood and bone marrow cancer with defined genetic changes.